Editing Prostate Cancer: Diagnosis and evaluation (section)

====== NCCN ======
*'''NCCN (version 2.2021)'''
** '''<span style="color:#ff0000">Recommended (5):'''
**# '''<span style="color:#ff0000">Ashkenazi Jewish ancestry'''
**#'''<span style="color:#ff0000">Positive family history of high-risk germline mutations (e.g. BRCA 1/2, Lynch syndrome)'''
**#* '''BRCA-cancers (5): breast, ovarian, pancreatic, prostate, melanoma'''
**#* '''Lynch syndrome cancers: (8) colonic (most common), endometrial (second most common), prostate, urothelial, adrenal, gastric, pancreatic, uterine, ovarian, and sebaceous carcinomas'''
**#'''<span style="color:#ff0000">Personal history of breast cancer'''
**#'''<span style="color:#ff0000">Metastatic (distant or regional (node-positive) prostate cancer'''
**# '''<span style="color:#ff0000">High- or very-high risk localized prostate cancer'''
** '''Optional (2)'''
**# '''Intermediate-risk with intraductal or cribiform histology'''
**# '''Personal history of colorectal, gastric, melanoma, upper tract urothelial, glioblastoma, biliary tract, or small intestine'''